Page 52 - 南京医科大学学报自然科学版
P. 52
第41卷第12期
·1758 · 南 京 医 科 大 学 学 报 2021年12月
鼠疫的临床治疗通常以链霉素联用其他类型 [6] 吴智远,焦 磊,徐 兵,等. 抗鼠疫耶尔森菌 F1 抗原
抗生素为主。在预防鼠疫方面,灭活疫苗已投入临 单克隆抗体对小鼠的被动免疫保护作用[J]. 微生物学
床应用近百年,尽管近年来已研制出亚单位疫苗及 免疫学进展,2018,46(1):7-13
DNA 疫苗,但有待临床试验验证其安全性及有效 [7] 林 芸,阎锡蕴. 人源化抗体研究历程及发展趋势[J].
生物工程学报,2004,20(1):1-5
性。近年来发现多种耐药鼠疫杆菌,单纯的药物治
[8] AMIRI M M,BAHADORI T,SOLTANTOYEH T,et al.
疗效果不明显 [12-14] ,随着恐怖主义势力抬头,耐药鼠
Development of a novel inhibitory chimeric anti ⁃ HER2
疫杆菌被应用于生化武器研发,高效鼠疫治疗方案 monoclonal antibody[J]. Iran J Immunol,2019,16(1):
的开发被提上日程。本研究制备的抗 F1 嵌合抗体 26-42
可以与F1抗原特异性结合,可有效应用于鼠疫检测 [9] VERHOEYEN M E,SAUNDERS J A,PRICE M R,et al.
与治疗。在后续研究中,需进行动物实验及临床试 Construction of a reshaped HMFG1 antibody and compari⁃
验,分析其安全性及保护效率,为人源化中和抗体 son of its fine specificity with that of the parent mouse an⁃
应用于鼠疫临床救治奠定基础。 tibody[J]. Immunology,1993,78(3):364-370
[10] WALTHER C G,WHITFIELD R,JAMES D C. Impor⁃
[参考文献]
tance of interaction between integrin and actin cytoskele⁃
[1] BRAMANTI B,STENSETH N C,WALLØE L. Plague:a ton in suspension adaptation of CHO cells[J]. Appl Bio⁃
disease which changed the path of human civilization[J]. chem Biotechnol,2016,178(7):1286-1302
Adv Exp Med Biol,2016,918:1-26 [11] CHAHAR D S,RAVINDRAN S,PISAL S S. Monoclonal
[2] BRUBAKER R R. physiology of yersinia pestis[J]. Adv⁃ antibody purification and its progression to commercial
Exp Med Biol,2016,918:79-99 scale[J]. Biologicals,2020,63:1-13
[3] RAI R,DAS B,CHOUDHARY N,et al. MAP of F1 and V [12] CABANEL N,BOUCHIER C,RAJERISON M,et al. Plas⁃
antigens from Yersinia pestis astride innate and adaptive mid⁃mediated doxycycline resistance in a Yersinia pestis
immune response[J]. Microb Pathog,2015,87:13-20 strain isolated from a rat[J]. Int J Antimicrob Agents,
[4] GAHLOT D K,IFILL G,MACINTYRE S. Optimised het⁃ 2018,51(2):249-254
erologous expression and functional analysis of the Yersin⁃ [13] PLATONOV M E,SVETOCH T E,EVSEEVA V V,et al.
ia pestis F1 ⁃ capsular antigen regulator Caf1R[J]. Int J Polymorphism of the cysteine protease YopT from Yersin⁃
Mol Sci,2021,22(18):9805 ia pestis[J]. Protein Pept Lett,2016,23(4):379-385
[5] CHATTERJEE S,LESNIAK W G,GABRIELSON M,et [14] DAI R,HE J,ZHA X,et al. A novel mechanism of strepto⁃
al. A humanized antibody for imaging immune checkpoint mycin resistance in Yersinia pestis:mutation in the rpsL⁃
ligand PD⁃L1 expression in tumors[J]. Oncotarget,2016, gene[J]. PLoS Negl Trop Dis,2021,15(4):e0009324
7(9):10215-10227 [收稿日期] 2021-06-03
欢迎关注我刊微博、微信公众号!

